Characteristics of Interstitial Fibrosis and Inflammatory Cell Infiltration in Right Ventricles of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension

被引:62
|
作者
Overbeek, Maria J. [1 ]
Mouchaers, Koen T. B. [1 ]
Niessen, Hans M. [2 ,3 ]
Hadi, Awal M. [1 ]
Kupreishvili, Koba [2 ]
Boonstra, Anco [1 ]
Voskuyl, Alexandre E. [4 ]
Belien, Jeroen A. M. [2 ]
Smit, Egbert F. [1 ]
Dijkmans, Ben C. [4 ]
Vonk-Noordegraaf, Anton [1 ]
Grunberg, Katrien [2 ]
机构
[1] Vrije Univ Amsterdam, VU Univ Med Ctr, Dept Pulm Dis, Boelelaan 1117, NL-1007 MB Amsterdam, Netherlands
[2] Vrije Univ Amsterdam, VU Univ Med Ctr, Dept Pathol, NL-1007 MB Amsterdam, Netherlands
[3] Vrije Univ Amsterdam, VU Univ Med Ctr, Dept Cardiac Surg, NL-1007 MB Amsterdam, Netherlands
[4] Vrije Univ Amsterdam, VU Univ Med Ctr, Dept Rheumatol, NL-1007 MB Amsterdam, Netherlands
关键词
D O I
10.1155/2010/604615
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. Systemic sclerosis-associated pulmonary arterial hypertension (SScPAH) has a disturbed function of the right ventricle (RV) when compared to idiopathic PAH (IPAH). Systemic sclerosis may also affect the heart. We hypothesize that RV differences may occur at the level of interstitial inflammation and-fibrosis and compared inflammatory cell infiltrate and fibrosis between the RV of SScPAH, IPAH, and healthy controls. Methods. Paraffin-embedded tissue samples of RV and left ventricle (LV) from SScPAH (n = 5) and IPAH (n = 9) patients and controls (n = 4) were picrosirius red stained for detection of interstitial fibrosis, which was quantified semiautomatically. Neutrophilic granulocytes (MPO), macrophages (CD68), and lymphocytes (CD45) were immunohistochemically stained and only interstitial leukocytes were counted. Presence of epi-or endocardial inflammation, and of perivascular or intimal fibrosis of coronary arteries was assessed semiquantitatively (0-3: absent to extensive). Results. RV's of SScPAH showed significantly more inflammatory cells than of IPAH (cells/mm(2), mean +/- sd MPO 11 +/- 3 versus 6 +/- 1; CD68 11 +/- 3 versus 6 +/- 1; CD45 11 +/- 1 versus 5 +/- 1, P < .05) and than of controls. RV interstitial fibrosis was similar in SScPAH and IPAH (4 +/- 1 versus 5 +/- 1%, P = .9), and did not differ from controls (5 +/- 1%, P = .8). In 4 SScPAH and 5 IPAH RV's foci of replacement fibrosis were found. No differences were found on epi-or endocardial inflammation or on perivascular or intimal fibrosis of coronary arteries. Conclusion. SScPAH RVs display denser inflammatory infiltrates than IPAH, while they do not differ with respect to interstitial fibrosis. Whether increased inflammatory status is a contributor to altered RV function in SScPAH warrants further research.
引用
收藏
页数:10
相关论文
共 50 条
  • [21] Iron deficiency in patients with systemic sclerosis-associated pulmonary arterial hypertension
    Ruiter, Gerrina
    Voskuyl, Alexandre
    Lanser, Irene
    de Man, Frances
    Postmus, Pieter
    Wharton, John
    Westerhof, Nico
    van der Laarse, Willem
    Howard, Luke
    Wilkins, Martin
    Vonk-Noordegraaf, Anton
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40
  • [22] Severity of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension in African Americans
    Blanco, Isabel
    Mathai, Stephen
    Shafiq, Majid
    Boyce, Danielle
    Kolb, Todd M.
    Chami, Hala
    Hummers, Laura K.
    Housten, Traci
    Chaisson, Neal
    Zaiman, Ari L.
    Wigley, Fredrick M.
    Tedford, Ryan J.
    Kass, David A.
    Damico, Rachel
    Girgis, Reda E.
    Hassoun, Paul M.
    MEDICINE, 2014, 93 (05) : 177 - 185
  • [23] Treatment regimens and outcome of systemic sclerosis-associated pulmonary arterial hypertension
    Bjorkekjaer, Hj
    Fretheim, H.
    Inselseth, Hm
    Midtvedt, O.
    Barua, I.
    Garen, T.
    Bitter, H.
    Andreassen, A.
    Molberg, O.
    Broch, K.
    Hoffmann-Vold, A.
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2021, 50 : 56 - 58
  • [24] Treatment Regimens and Outcomes in Systemic Sclerosis-associated Pulmonary Arterial Hypertension
    Bjorkekjaer, Hilde Jenssen
    Fretheim, Havard
    Inselseth, Helene Marjavara
    Midtvedt, Oyvind
    Barua, Imon
    Garen, Torhild
    Bitter, Helle
    Andreassen, Arne
    Molberg, Oyvind
    Broch, Kaspar
    Hoffmann-Vold, Anna-Maria
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 1116 - 1118
  • [25] Time for precision medicine in systemic sclerosis-associated pulmonary arterial hypertension
    Launay, David
    Sanges, Sebastien
    Sobanski, Vincent
    EUROPEAN RESPIRATORY JOURNAL, 2021, 57 (06)
  • [26] The Impact of Progressive Pulmonary Fibrosis in Systemic Sclerosis-Associated Interstitial Lung Disease
    Martin-Lopez, Maria
    Carreira, Patricia E.
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (20)
  • [27] SEX DISPARITIES IN SURVIVAL OF SYSTEMIC SCLEROSIS-ASSOCIATED PULMONARY ARTERIAL HYPERTENSION AND IDIOPATHIC PULMONARY ARTERIAL HYPERTENSION PATIENTS
    Pasarikovski, C. R.
    Granton, J. T.
    Lee, P.
    Roos, A. M.
    Kron, A. T.
    Chau, C.
    Johnson, S. R.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2014, 32 (02) : S87 - S87
  • [28] Sex Disparities In Survival Of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension and Idiopathic Pulmonary Arterial Hypertension Patients
    Pasarikovski, Christopher
    Granton, John T.
    Lee, Peter
    Roos, Adrienne M.
    Kron, Amie T.
    Chau, Cathy
    Johnson, Sindhu R.
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S1099 - S1099
  • [29] Sex Disparities in Survival of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension and Idiopathic Pulmonary Arterial Hypertension Patients
    Pasarikovski, Christopher
    Granton, John
    Lee, Peter
    Roos, Adrienne
    Kron, Amie
    Chau, Cathy
    Johnson, Sindhu
    JOURNAL OF RHEUMATOLOGY, 2013, 40 (06) : 1016 - 1016
  • [30] Differences in Right Ventricular Functional Changes during Treatment between Systemic Sclerosis-associated Pulmonary Arterial Hypertension and Idiopathic Pulmonary Arterial Hypertension
    Argula, Rahul G.
    Karwa, Abhijit
    Lauer, Abigail
    Gregg, David
    Silver, Richard M.
    Feghali-Bostwick, Carol
    Schanpp, Lynn M.
    Egbert, Kim
    Usher, Bruce W.
    Ramakrishnan, Viswanathan
    Hassoun, Paul M.
    Strange, Charlie
    ANNALS OF THE AMERICAN THORACIC SOCIETY, 2017, 14 (05) : 682 - 689